Grant, deny, or reassess the role of yttrium-90 in hepatocellular carcinoma?
- PMID: 29107680
- DOI: 10.1016/S1470-2045(17)30687-3
Grant, deny, or reassess the role of yttrium-90 in hepatocellular carcinoma?
Comment on
-
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.Lancet Oncol. 2017 Dec;18(12):1624-1636. doi: 10.1016/S1470-2045(17)30683-6. Epub 2017 Oct 26. Lancet Oncol. 2017. PMID: 29107679 Clinical Trial.
Similar articles
-
Hepatic arterial yttrium 90 microspheres: another treatment option for hepatocellular carcinoma.J Vasc Interv Radiol. 2005 Feb;16(2 Pt 1):161-4. doi: 10.1097/01.RVI.0000152059.47260.C7. J Vasc Interv Radiol. 2005. PMID: 15713916 No abstract available.
-
Radioembolization for hepatocellular carcinoma: The time has come.Hepatology. 2018 Mar;67(3):820-822. doi: 10.1002/hep.29590. Epub 2018 Jan 24. Hepatology. 2018. PMID: 29023925 No abstract available.
-
Yttrium-90 Radioembolization for Hepatocellular Carcinoma Prior to Liver Transplantation.World J Surg. 2017 Nov;41(11):2976. doi: 10.1007/s00268-017-4011-x. World J Surg. 2017. PMID: 28349323 No abstract available.
-
Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.Int J Clin Pract. 2017 Nov;71(11). doi: 10.1111/ijcp.12972. Epub 2017 Jul 30. Int J Clin Pract. 2017. PMID: 28758319 Review.
-
Yttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature Review.Korean J Radiol. 2016 Jul-Aug;17(4):472-88. doi: 10.3348/kjr.2016.17.4.472. Epub 2016 Jun 27. Korean J Radiol. 2016. PMID: 27390539 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical